SeaSpine Launches Shoreline Anterior Cervical Standalone System
SeaSpine commenced full commercial launch of Shoreline®, its anterior cervical standalone system. Sep 26, 2017
Stryker Serrato Pedicle Screws Reach 100 Surgeon Users
Stryker’s Serrato™ Pedicle Screws have been implanted by >100 U.S. surgeons during the first 30 days of initial launch. Sep 26, 2017
Mortise Medical Receives FDA Clearance for LigaMetrics Suture Anchor
Mortise Medical received FDA 510(k) clearance to market the LigaMetrics™ Suture Anchor for ankle injury repair.  Sep 26, 2017
DiscGenics Raises $14 Million for Injectable Cell Therapy
DiscGenics closed a US $14MM Series B financing. Funds will support regulatory approvals and manufacturing ramp-up for Phase III clinical and commercial production of its cell therapy for treatment of degenerative disc disease. Sep 26, 2017
Paragon 28 Introduces Posterior Plates
Paragon 28 launched posterior plates for its Gorilla® Ankle Fracture system. Sep 26, 2017
Viseon Spine Closes $5 Million Series A Financing
Viseon Spine closed a US $5.0MM Series A financing. The company is developing single-use, disposable visualization and illumination technologies for minimally invasive spine procedures. Sep 26, 2017
Flower Orthopedics Expands Ready-For-Surgery Line
New product launches from Flower Orthopedics include updated instruments in the Flower E-Kit™ system; FlowerGraft™, a foot reconstruction platform with pre-shaped allografts packaged in saline; and the addition of Headless Compression Screws to the Ready-for-Surgery™ cannulated screw set. Sep 26, 2017
HCT Regenerative to Distribute LifeLink Allografts in Taiwan
LifeLink Tissue Bank will provide allografts to treat sports, orthopaedic and spine injuries to HCT Regenerative, for distribution in Taiwan. Sep 25, 2017
Amedica 1Q/2Q17 Preliminary Revenue & Business Update
Amedica announced preliminary 1Q17 revenue of US $2.6MM, -37.7% vs. 1Q16, and 2Q17 revenue of $3.2MM, -20.0% vs. 2Q16, totaling preliminary 1H17 revenue of $5.8MM, -29.0% vs. 1H16. Sep 25, 2017
Bone Therapeutics and Asahi Kasei Sign Exclusive License Agreement for PREOB
Bone Therapeutics signed an exclusive license agreement with Asahi Kasei to develop and commercialize PREOB® autologous bone cell therapy. Sep 22, 2017
